ArticlePloS one2026

Evaluation of the mechanism underlying melatonin action in cholestatic liver disease treatment via network pharmacology, molecular docking, and in vivo experiments.

Tao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.